Rotavirus overview

Pediatric Infectious Disease Journal

Volumn 28, Issue SUPPL. 3, 2009, Pages

  Bernstein, David I ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Diagnosis; Epidemiology; Gastroenteritis; Rotavirus; Rotavirus vaccine; Treatment

Indexed keywords

INFUSION FLUID; ORAL REHYDRATION SOLUTION; ROTAVIRUS VACCINE;

CHILD HOSPITALIZATION; CHILDHOOD DISEASE; DIARRHEA; DISEASE COURSE; DISEASE SEVERITY; DRUG APPROVAL; DRUG EFFICACY; FEVER; FLUID THERAPY; FOOD AND DRUG ADMINISTRATION; HEALTH CARE COST; HUMAN; LABORATORY TEST; ORAL REHYDRATION THERAPY; PRIORITY JOURNAL; REPEATED DRUG DOSE; REVIEW; ROTAVIRUS; SYMPTOM; VACCINATION; VIRAL GASTROENTERITIS; VIRUS INFECTION; VOMITING; GASTROENTERITIS; INFANT; NEWBORN; PRESCHOOL CHILD; PREVALENCE; VIROLOGY;

CHILD, PRESCHOOL; GASTROENTERITIS; HUMANS; INFANT; INFANT, NEWBORN; PREVALENCE; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINATION;

EID: 63849112854     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181967bee     Document Type: Article

References (25)

1. Centers for Disease Control and Prevention. Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2006; 55(RR-12):1-16.
2. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. Atkinson W, Hamborsky J, McIntyre L, et al, eds. 10th ed. Washington, DC: Public Health Foundation; 2007:295- 306.
3. Coffin SE, Elser J, Marchant C, et al. Impact of acute rotavirus gastroenteritis on pediatric outpatient practices in the United States. Pediatr Infect Dis J. 2006;25:584 -589.
4. Kapikian AZ. Viral gastroenteritis. JAMA. 1993;269:627- 629.
5. Glass RI. New hope for defeating rotavirus. Sci Am. 2006;294:46 -51, 54-55.
6. Malek MA, Curns AT, Holman RC, et al. Diarrhea- and rotavirus-associated hospitalizations among children less than 5 years of age: United States, 1997 and 2000. Pediatrics. 2006;117:1887-1892.
7. Dennehy PH, Cortese MM, Be'gue' RE, et al. A case-control study to determine risk factors for hospitalization for rotavirus gastroenteritis in U.S. children. Pediatr Infect Dis J. 2006;25:1123-1131.
8. Avendaño P, Matson DO, Long J, et al. Costs associated with office visits for diarrhea in infants and toddlers. Pediatr Infect Dis J. 1993;12:897-902.
9. Zimmerman CM, Bresee JS, Parashar UD, et al. Cost of diarrhea-associated hospitalizations and outpatient visits in an insured population of young children in the United States. Pediatr Infect Dis J. 2001;20:14 -19.
10. Chang HG, Glass RI, Smith PF, et al. Disease burden and risk factors for hospitalizations associated with rotavirus infection among children in New York State, 1989 through 2000. Pediatr Infect Dis J. 2003;22:808-814.
11. Lee BP, Azimi PH, Staat MA, et al. Nonmedical costs associated with rotavirus disease requiring hospitalization. Pediatr Infect Dis J. 2005;24:984-988.
12. Fischer TK, Viboud C, Parashar U, et al. Hospitalizations and deaths from diarrhea and rotavirus among children -5 years of age in the United States, 1993-2003. J Infect Dis. 2007;195:1117-1125.
13. Hsu VP, Staat MA, Roberts N, et al. Use of active surveillance to validate international classification of diseases code estimates of rotavirus hospitalizations in children. Pediatrics. 2005;115:78-82.
14. Bernstein DI, Ward RL. Rotaviruses. In: Feigin RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases. 5th ed. Vol 2. Philadelphia, PA: Saunders; 2004:2110 -2133.
15. Dennehy PH. Rotavirus vaccines: an overview. Clin Microbiol Rev. 2008; 21:198 -208.
16. Glass RI, Parashar UD, Bresee JS, et al. Rotavirus vaccines: current prospects and future challenges. Lancet. 2006;368:323-332.
17. Parashar UD, Holman RC, Clarke MJ, et al. Hospitalizations associated with rotavirus diarrhea in the United States, 1993 through 1995: surveillance based on the new ICD-9-CM rotavirus-specific diagnostic code. J Infect Dis. 1998;177:13-17.
18. Staat MA, Azimi PH, Berke T, et al. Clinical presentations of rotavirus infection among hospitalized children. Pediatr Infect Dis J. 2002;21:221- 227.
19. Centers for Disease Control and Prevention. Delayed onset and diminished magnitude of rotavirus activity-United States, November 2007-May 2008. MMWR. 2008;57:1- 4.
20. Santos N, Hosino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol. 2005;15:29 -56.
21. Griffin DD, Kirkwood CD, Parashar UD, et al. Surveillance of rotavirus strains in the United States: identification of unusual strains. The National Rotavirus Strain Surveillance System collaborating laboratories. J Clin Microbiol. 2000;38:2784 -2787.
22. Bass ES, Pappano DA, Humiston SG. Rotavirus. Pediatr Rev. 2007;28: 183-191.
23. Anderson EJ, Weber SG. Rotavirus infection in adults. Lancet Infect Dis. 2004;4:91-99.
24. World Health Organization. Oral rehydration salts (ORS): a new reduced osmolarity formulation. Available at: http://www.who.int/child-adolescenthealth/ New-Publications/NEWS/Statement.htm. Accessed May 24, 2006.
25. Rotarix (live, attenuated human rotavirus -HRV- vaccine, oral) Prescribing Information. Research Triangle Park, NC: GlaxoSmithKline; 2008.